Friday, July 18, 2025
  • Login
Forbes 40under40
  • Home
  • Technology
  • Innovation
  • Real Estate
  • Leadership
  • Money
  • Lifestyle
No Result
View All Result
  • Home
  • Technology
  • Innovation
  • Real Estate
  • Leadership
  • Money
  • Lifestyle
No Result
View All Result
Forbes 40under40
No Result
View All Result
Home Lifestyle

Stocks to watch: OCBC, Fu Yu, TalkMed

by Mark Darwin
in Lifestyle
Stocks to watch: OCBC, Fu Yu, TalkMed
Share on FacebookShare on Twitter


[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Monday (Jun 30):

OCBC: The local bank announced in an e-mail sent to customers on Jun 27 that it will cut interest rates for its 360 Account, in line with lower interest rate expectations. With effect from Aug 1, the maximum interest rate of its flagship savings account will be lowered to 5.45 per cent per annum on the first S$100,000, from the current 6.3 per cent. This is the second time this year that OCBC has trimmed rates for the 360 Account, having announced in March that it would cut the maximum rate to 6.3 per cent per annum for the first S$100,000, from 7.65 per cent, on May 1. Its shares closed up 0.7 per cent or S$0.12 at S$16.35 on Friday, prior to the rate revision announcement.

Fu Yu: The components manufacturer on Sunday announced the appointments of four new independent, non-executive directors at its annual general meeting on Jun 27. This follows the resignation of three of the group’s independent, non-executive directors on Jun 11, after attempts by its largest shareholder to have two of them removed, which left Fu Yu with no independent directors and its group chief executive officer David Seow as the sole director. The counter ended Friday 2.1 per cent or S$0.002 higher at S$0.097.

TalkMed Group: The acquisition of tertiary healthcare service provider TalkMed Group by Tamarind Health has been approved by the Competition and Consumer Commission of Singapore (CCCS). Earlier on Dec 23, 2024, a special purpose vehicle managed by Tamarind Health, TW Troy, proposed to privatise the mainboard-listed group by way of scheme of arrangement at S$0.456 per share. The competition watchdog said in a statement last Friday that it had assessed that the transaction will not substantially lessen competition within the Singapore market. Shares of TalkMed closed flat at S$0.45 on Friday, before CCCS’ announcement.

Copyright SPH Media. All rights reserved.

Tags: OCBCStocksTalkMedWatch
Mark Darwin

Mark Darwin

Next Post
Apple supplier Lens Technology seeks up to HK.8 billion in Hong Kong listing

Apple supplier Lens Technology seeks up to HK$4.8 billion in Hong Kong listing

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.

 
 
 
 

NEWS

  • Forbes Magazine
  • Technology
  • Innovation
  • Money
  • Leadership
  • Real Estate
  • Lifestyle
Instagram Facebook Youtube

© 2024 Forbes 40under40. All Rights Reserved.

  • About Us
  • Advertise
  • Contact Us
No Result
View All Result
  • Home
  • Technology
  • Innovation
  • Real Estate
  • Leadership
  • Money
  • Lifestyle

© 2024 Forbes 40under40. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In